{"answers":{"affected":"It affects 7 products.","exploited":"There is no known exploitation of CVE-2022-43557 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2022-43557 yet. Limit exposure of the affected software until one is available.","what":"CVE-2022-43557 is a medium-severity missing authorization vulnerability in Becton, Dickinson and Company (BD) BodyGuard™ Pump, published on 5 Dec 2022. It can only be exploited from the same machine or local network, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2022-43557 and fix it if it is affected.\n\nWhat it is: CVE-2022-43557 is a medium-severity missing authorization vulnerability in Becton, Dickinson and Company (BD) BodyGuard™ Pump, published on 5 Dec 2022. It can only be exploited from the same machine or local network, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2022-43557 in the wild and no public exploit code.\n\nAffected product: Becton, Dickinson and Company (BD) BodyGuard™ Pump. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2022-43557/ (Markdown: https://insights.sbomify.com/CVE-2022-43557/index.md)","id":"CVE-2022-43557","markdown":"https://insights.sbomify.com/CVE-2022-43557/index.md","name":"CVE-2022-43557","record":{"aliases":["GHSA-42mr-mfcr-7jqh"],"analysis":{"component_type":"iot_embedded","fix_type":"no_fix_stated","impacts":["data_modify","denial_of_service"],"network_reachable":"adjacent_or_local","non_default_config":false,"product_category":"Infusion pump","requires_auth":"none","summary":"Attackers with physical access can configure or disable BD BodyGuard infusion pumps via the RS-232 interface due to missing authorization checks.","user_interaction":"not_required","vuln_class":"missing_authorization"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"BD","cpe":[{"product":"bodyguard_121_twins_firmware","vendor":"bd"},{"product":"bodyguard_323_colorvision_firmware","vendor":"bd"},{"product":"bodyguard_999-603_firmware","vendor":"bd"},{"product":"bodyguard_duo_999-903_firmware","vendor":"bd"},{"product":"bodyguard_epidural_999-683_firmware","vendor":"bd"},{"product":"bodyguard_pain_manager_999-803_firmware","vendor":"bd"},{"product":"bodyguard_t_999-103_firmware","vendor":"bd"}],"cvss":{"score":5.3,"severity":"medium","source":"cna","vector":"CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H","version":"3.1"},"cwes":[{"id":"CWE-287","name":"Improper Authentication"},{"id":"CWE-1299","name":"Missing Protection Mechanism for Alternate Hardware Interface"}],"description":"The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"BD BodyGuard™ Pumps – RS-232 Interface Vulnerability","id":"CVE-2022-43557","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"missing_authorization","year":"2022"},"n_packages":0,"n_references":1,"next":{"headline":"** REJECT ** DO NOT USE THIS CANDIDATE NUMBER.","id":"CVE-2022-43558"},"packages":[],"prev":{"headline":"Concrete CMS vulnerable to cross-site scripting in the text input field","id":"CVE-2022-43556"},"products":["BodyGuard™ Pump"],"published":"2022-12-05","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2025-04-23","vendors":["Becton, Dickinson and Company (BD)"]},"summary":"Attackers with physical access can configure or disable BD BodyGuard infusion pumps via the RS-232 interface due to missing authorization checks.","url":"https://insights.sbomify.com/CVE-2022-43557/"}